An international biopharmaceutical company focused on rare diseases, Sobi gives people access to life-transforming haematology and immunology treatments.
People also ask
What does Sobi make?
Who bought Sobi?
Where is Sobi based?
How big is Sobi?
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Learn more about us here.
Missing: PRODUCTION | Show results with:PRODUCTION
Mar 23, 2022 · Sobi® today announced that its contract with Pfizer for the manufacture of drug substance for ReFacto AF®/Xyntha® (ReFacto) has been amended ...
Jun 17, 2022 · The facility is designed to produce biologically innovative drugs to treat rare diseases, which will be exported to 50 markets, making them more ...
Sobi's R&D pipeline: colour-coded chart showing haematology, immunology, and specialty care treatments in phases 1, 2 and 3 and at the registration stage.
Missing: PRODUCTION | Show results with:PRODUCTION
Our R&D is focused on late-stage research within the areas of Haematology and Immunology, where our pre-market assets represent considerable value.
Missing: PRODUCTION | Show results with:PRODUCTION
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care ...
Missing: PRODUCTION | Show results with:PRODUCTION
Sobi is an international specialty healthcare company dedicated to developing treatments and extensive patient support networks for people with rare and ...
Missing: PRODUCTION | Show results with:PRODUCTION
Responsible sourcing. As our supply chain is outsourced, it relies on sustainable and dependable suppliers to produce, pack, and distribute medicines.
Missing: PRODUCTION | Show results with:PRODUCTION
Mar 23, 2022 · Sobi will start the process of downsizing its Stockholm manufacturing facility in the second half of 2022, with the last volumes being delivered ...
People also search for